MacroGenics
MGNX
$4.36
Share price
-14.75%
Change (1 day)
-28.44%
Change (1 year)
Categories
MacroGenics (MGNX) - P/B ratio
P/B ratio as of May 2024 : 2.10
According to MacroGenics's latest financial reports the company has a price-to-book ratio of 2.10.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
MacroGenics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.91 | 34.61% |
| 2022-12-31 | 2.90 | -29.27% |
| 2021-12-31 | 4.11 | -5.5% |
| 2020-12-31 | 4.35 | |
| 2019-12-31 | N/A | |
| 2018-12-31 | N/A | |
| 2017-12-31 | N/A | |
| 2016-12-31 | N/A | |
| 2015-12-31 | N/A | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 1.84 | -12.65% | 🇺🇸 USA |
 Eli Lilly LLY | 56.8 | 2,604.22% | 🇺🇸 USA |
 Amgen AMGN | 27.1 | 1,189.22% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.72 | 76.86% | 🇺🇸 USA |
 Merck MRK | 8.81 | 319.18% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 5.40 | 157.15% | 🇺🇸 USA |
 Xencor XNCR | 2.07 | -1.50% | 🇺🇸 USA |